The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats
@article{Need2005TheRO, title={The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats}, author={A. Need and R. J. Davis and J. Alexander-Chacko and B. Eastwood and E. Chernet and L. Phebus and D. Sindelar and G. Nomikos}, journal={Psychopharmacology}, year={2005}, volume={184}, pages={26-35} }
RationaleCannabinoid type 1 (CB1) receptor antagonists are reportedly effective in reducing food intake both preclinically and clinically. This may be due in part to their effects on monoamine release in the brain. The level of central CB1 receptor occupancy underlying these neurobiological effects is unclear.ObjectivesWe explored the relationship between in vivo CB1 receptor occupancy in the frontal cortex and changes in both monoamine release in the medial prefrontal cortex (mPFC) and feeding… CONTINUE READING
49 Citations
Prelimbic cortex 5-HT1A and 5-HT2C receptors are involved in the hypophagic effects caused by fluoxetine in fasted rats
- Chemistry, Medicine
- Pharmacology Biochemistry and Behavior
- 2015
- 4
In vivo rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously.
- Chemistry, Medicine
- Life sciences
- 2007
- 36
Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation
- Chemistry, Medicine
- Neurochemistry International
- 2012
- 29
Immunohistochemical localization of CB1 cannabinoid receptors in frontal cortex and related limbic areas in obese Zucker rats: Effects of chronic fluoxetine treatment
- Medicine
- Brain Research
- 2008
- 8
5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion
- Medicine
- Pharmacology Biochemistry and Behavior
- 2013
- 20
Medial amygdaloid nucleus 5-HT2C receptors are involved in the hypophagic effect caused by zimelidine in rats
- Chemistry, Medicine
- Neuropharmacology
- 2012
- 5
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
- Chemistry, Medicine
- European journal of pharmacology
- 2008
- 12
MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice
- Medicine
- Behavioural pharmacology
- 2011
- 7
- Highly Influenced
Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model
- Medicine
- European Journal of Nuclear Medicine and Molecular Imaging
- 2012
- 20
Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists
- Psychology, Medicine
- Pharmacology Biochemistry and Behavior
- 2010
- 6
References
SHOWING 1-10 OF 45 REFERENCES
The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
- Psychology, Medicine
- British journal of pharmacology
- 2003
- 262
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
- Medicine
- Behavioural pharmacology
- 2002
- 385
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding
- Chemistry, Medicine
- The Journal of Neuroscience
- 2002
- 471
- PDF
Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats
- Chemistry, Medicine
- Neuropharmacology
- 2002
- 146
Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity
- Biology, Medicine
- Neurobiology of Disease
- 1998
- 156
- PDF
CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents
- Biology, Medicine
- Behavioural pharmacology
- 2004
- 200
Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats
- Chemistry, Medicine
- Journal of Neural Transmission
- 2005
- 39
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
- Biology, Medicine
- Molecular pharmacology
- 2001
- 529
- PDF
Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice.
- Biology, Medicine
- Biochemical and biophysical research communications
- 2002
- 78
Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281
- Chemistry, Medicine
- Synapse
- 2000
- 60
- Highly Influential